Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Albemarle Names John Steitz COO

RELATED NEWS
Trade ALB now with 

Albemarle Corp. (ALB: Quote), Monday said it has appointed John Steitz as President and Chief Operating Officer of the company, effective March 1, 2012.

Steitz, in this new role, will oversee all aspects of the company's operations, including global responsibility for manufacturing, supply chain, sales and health, safety and environmental.

"John is a recognized leader in the specialty chemicals arena and has served Albemarle with incredible leadership and dedication. With a deep knowledge of both our businesses and the chemical industry and a true passion for executing our strategies, he is the ideal fit for this position," said Luke Kissam, Chief Executive Officer of Albemarle.

Click here to receive FREE breaking news email alerts for Albemarle Corp and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Stocks moved notably higher over the course of the trading day on Friday after initially showing a lack of direction. The gains on the day extended the recent upward trend by the markets, with the tech-heavy Nasdaq reaching its best closing level in almost a month. Looking to capitalize on news of an Ebola diagnosis in New York City, Republican Senate candidate Scott Brown issued a statement Friday criticizing his Democratic opponent Sen. Jeanne Shaheen, D-N.H., for "waffling" on a travel ban. In another troubling sign for Democrats, the results of a Gallup poll released on Friday show that Tea Party Republicans are much more motivated to vote in the upcoming midterm elections than other Americans. The poll found that 73 percent of Tea Party Republicans are "extremely" or "very" motivated to vote in this year's elections.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.